EUVIMEDEUVIMED entdecken
EUVIMED · CrossrefZeitschrift

Transplantation and Cellular Therapy

ISSN 2666-6367 · Elsevier BV

Neueste Artikel

  1. Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall Survival

    Gurbakhash Kaur, Jennifer Logue, Ruta Brazauskas, Temitope Oloyede, Muhammad Bilal Abid, Sairah Ahmed, Mahmoud Aljurf, Rahul Banerjee, Asad Bashey, Amer M. Beitinjaneh, Natalie S. Callander, Paul Castillo, Bhagirathbhai Dholaria, Scott R. Goldsmith, Shahrukh Hashmi, Mohamed A. Kharfan-Dabaja, Hongtao Liu, Hira Mian, Taiga Nishihori, Kai Rejeski, Ayman Saad, Michael J. Slade, Cameron J. Turtle, Dan T. Vogl, Kirsten M. Williams, Baldeep Wirk, Marcelo C. Pasquini, Amy Moskop, Othman Salim Akhtar, Doris K. Hansen, Murali Janakiram

    Erschienen: 2026-11DOI: 10.1016/j.jtct.2026.06.021

  2. Infections Within 100 Days of Idecabtagene Vicleucel and Impact on Survival for Relapsed/Refractory Multiple Myeloma: A CIBMTR Analysis

    Kitsada Wudhikarn, Lohith Gowda, Qiran Ye, Temitope Oloyede, Michael Martens, Rahul Banerjee, Srinivas S. Devarakonda, Hongtao Liu, Megan M. Herr, Jo-Anne H. Young, Tania Jain, Ajoy Dias, Taiga Nishihori, Abu-Sayeef Mirza, Siddhartha Ganguly, Amer M. Beitinjaneh, Mahmoud Aljurf, Baldeep Wirk, Nosha Farhadfar, Yvonne A. Efebera, Miguel-Angel Perales, Christen L. Ebens, Hemant S Murthy, Joshua A. Hill, Christopher E. Dandoy, Sanghee Hong, Zeinab El Boghdadly, Othman Salim Akhtar, Jeffery J. Auletta, Anna R. Huppler, Muhammad Bilal Abid

    Erschienen: 2026-11DOI: 10.1016/j.jtct.2026.06.029

  3. Exercise Prehabilitation for Older Adults Undergoing CAR-T: Feasibility, Acceptability, and Preliminary Outcomes

    Nathan H. Parker, Jongphil Kim, Morgan Bean, Mart Theodore De Vera, Rachel Carmella, Adam Duca, Salvatore Corallo, Luis Cuadrado Delgado, Emily Merritt, Jessica McCoy, Ashlyn Brushwood, Mia Franca, Doris K. Hansen, Omar Castaneda Puglianini, Aleksandr Lazaryan, Julio Chavez, Taiga Nishihori, Bijal Shah, Rawan Faramand, Abu-Sayeef Mirza, Othman Akhtar, Lauren C. Peres, Nicholas B. Figura, Khushali Jhaveri, Laura B. Oswald, Heather S.L. Jim, Frederick L. Locke, Michael Jain, Ciara L. Freeman

    Erschienen: 2026-11DOI: 10.1016/j.jtct.2026.06.030

  4. Comparison of Carmustine-, Lomustine-, and Nitrosourea-Free Conditioning Regimens for Autologous HCT (Auto-HCT) in Lymphoma: Results From the Hematopoietic Cell Transplantation Brazilian Registry (HCTBR)

    Abrahão Elias Hallack Neto, Vanderson Rocha, Eliana Miranda, Fernando B. Duarte, Nelson Hamerschlak, Carmen Bonfim, Antonio Vaz de Macedo, Vergilio A.R. Colturato, Decio Lerner, Phillip Scheinberg, Alexandre Silvério, George M.N. Barros, Marcos P. Colella, Samir K. Nabhan, Maria Claudia R. Moreira, Yana A.S. Novis, Jayr Schmidt Filho, Rodolfo D. de A Soares, Ricardo Chiattone, Rodolfo F. Calixto, Adriana Seber, Vinicius C. de Molla, Milton A.F. Aranha, Vaneuza A.M. Funke, Rafael D. Gaiolla, Rony Schaffel, Angelo Atalla, Liane E. Daudt, Joao Victor P. Feliciano, Mary E. Flowers, Afonso C. Vigorito

    Erschienen: 2026-11DOI: 10.1016/j.jtct.2026.06.032

  5. Haploidentical Versus HLA-matched Unrelated Donors for Hematopoietic Cell Transplantation in Acute Leukemia: A Multicenter Observational Study in a Developing Country Facilitated by Collaboration Between the CIBMTR and the Brazilian Society of Cellular Therapy and Bone Marrow Transplantation (SBTMO)

    Mariana Nassif Kerbauy, Leonardo Javier Arcuri, Vergilio Antonio Rensi Colturato, Mair Pedro Souza, Iago Colturato, Phillip Scheinberg, George Mauricio Navarro Barros, Maria Cristina Martins de Almeida Macedo, Vaneuza Araújo Moreira Funke, Andreza Alice Feitosa Ribeiro, Decio Lerner, Victor Gottardello Zecchin, Marcos Paulo Colella, Marcos Roberto Pedron Oltramari, Yana Augusta Novis Zogbi, Liane Esteves Daudt, Rodolfo Soares, Fernando Barroso Duarte, Adriana Seber, Jayr Schmidt Filho, Daniela Ferreira Dias, Maria Claudia Rodrigues Moreira, Afonso Celso Vigorito, Antonio Vaz de Macedo, Anderson Simione, Mariana Clapis Bello Velloso, Carmem Maria Sales Bonfim, Jinalben Patel, Marcelo Pasquini, Vanderson Rocha, Mary Evelyn Flowers, Nelson Hamerschlak

    Erschienen: 2026-11DOI: 10.1016/j.jtct.2026.06.033

  6. Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma

    Nausheen Ahmed, Alaa Ali, Soyoung Kim, Temitope Oloyede, Matthew Bye, Lohith Gowda, Rammurti T. Kamble, Abu-Sayeef Mirza, Kalyan V. Nadiminti, Priyanka A. Pophali, Carlos Rodriguez-Bonilla, Alex Sieg, Christopher Strouse, Muhammad Bilal Abid, Aimaz Afrough, Mahmoud Aljurf, Amer M. Beitinjaneh, Saurabh Chhabra, Michelle Choe, Talal Hilal, Madiha Iqbal, Tania Jain, Mohamed A. Kharfan-Dabaja, Dipenkumar Modi, Guillermo Orti, Attaphol Pawarode, Uttam Rao, Peter A. Riedell, Ayman Saad, Sachiko Seo, Anna Sureda Balari, John L. Wagner, Kitsada Wudhikarn, Cameron J. Turtle, Christine L. Phillips, Marcelo C. Pasquini, Sairah Ahmed, Siddhartha Ganguly, Amy Moskop

    Erschienen: 2026-11DOI: 10.1016/j.jtct.2026.06.035

  7. Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia: Results from the Real-World Outcomes Collaborative of Chimeric Antigen Receptor T in Adult Acute Lymphoblastic Leukemia

    Rawan G. Faramand, Amy Zhang, Gregory W. Roloff, Ibrahim Aldoss, Anjali S. Advani, Minoo Battiwalla, Jacob Boccucci, Kenneth Byrd, Ryan D. Cassaday, Matthew Connor, Kaitlyn C. Dykes, Talal Hilal, Noam E. Kopmar, Vamsi K. Kota, Catherine J. Lee, Jessica T. Leonard, Georgia R. Lill, Chenyu Lin, Aaron C. Logan, Navneet S. Majhail, Shahbaz A. Malik, Ross McCauley, Jozal Moore, Luke Mountjoy, Timothy O’Connor, Kristen M. O’Dwyer, Silvina Odstrcil Bobillo, Caspian H. Oliai, Tamer Othman, Aravind Ramakrishnan, Karam Sandhu, Marc Schwartz, Paul Shaughnessy, Hrishikesh K. Srinagesh, Katherine C. Sutherland, Virginia Tan, Stephanie B. Tsai, Matthew Ulrickson, Eunice S. Wang, George Yaghmour

    Erschienen: 2026-11DOI: 10.1016/j.jtct.2026.06.039

  8. Impact of Disease Biology and Bridging Strategy on Outcomes After CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma

    Irene Strassl, Alexander Nikoloudis, Lina Zoe Ruesing, Thomas Melchardt, Michael Leisch, Eduard Schulz, Annkristin Heine, Peter Neumeister, Normann Steiner, Dominik Wolf, Wolfgang Willenbacher, Petra Pichler-Izmir, Theresa Lentner, Johannes Clausen, Veronika Buxhofer-Ausch, Sigrid Machherndl-Spandl, Olga Saini, Dagmar Wipplinger, Holger Rumpold, Nina Worel, Werner Rabitsch, Axel Schulenburg, Hermine Agis, Maria-Theresa Krauth

    Erschienen: 2026-11DOI: 10.1016/j.jtct.2026.06.048

  9. Impact of Prior Chimeric Antigen Receptor T-Cell Treatment on Graft-Versus-Host Disease and Nonrelapse Mortality After Allogeneic Transplantation

    Tamer Othman, Dongyun Yang, Geoffrey Shouse, Hoda Pourhassan, Salman Otoukesh, Leonardo Farol, Leslie L. Popplewell, Ahmed Aribi, Alex F. Herrera, Joshua Mansour, Matthew Mei, Karamjeet S Sandhu, Tanya Siddiqi, Vaibhav Agrawal, Idoroenyi Amanam, Vinod Pullarkat, Tycel J. Phillips, Haris Ali, Lihua E. Budde, Ryotaro Nakamura, Stephen J Forman, Ibrahim Aldoss, Monzr M. Al Malki

    Erschienen: 2026-11DOI: 10.1016/j.jtct.2026.06.052

Jahrgänge

2026 · 1.4482025 · 1.1722024 · 1.0152023 · 9892022 · 1.0162021 · 1.009

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.